Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn Disease; Microbiome Intervention: Sponsors: Chinese University of Hong Kong; National Taiwan University; Hanoi Medical University; Mahidol University; Indonesia University; National University of Malaysia; Kiang Wu Hospital; National Academy of Medical Sciences, Nepal; Duke-NUS Graduate Medica l School; National University Hospital, Singapore; Heidelberg University; University of Chicago; Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2022 Category: Research Source Type: clinical trials